TITLE

Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?

PUB. DATE
December 2008
SOURCE
British Dental Journal;12/13/2008, Vol. 205 Issue 11, p597
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Does bone have to be exposed in bisphosphate necrosis of the jaws?
ACCESSION #
35657006

 

Related Articles

  • Anatomic Factors related to bisphosphonate Osteonecrosis of the Jaws: a Portuguese retrospective study. ÁLVARES FURTADO, Ivo; CALDAS, Cecília FRANCO; LANÇA, Fernanda; SALVADO E. SILVA, Francisco // Acta Medica Portuguesa;Mar/Apr2012, Vol. 25 Issue 2, p106 

    Aims: The objectives of this study of bisphosphonate-related osteonecrosis of the jaws (BRONJ) were to determine local distribution, possible anatomically associated or determinant factors and other bone involvement of the disease, contributing with this new data towards the establishment of its...

  • Osteoporoz Tanısı ile Oral Bisfosfonat Kullanan Hastada Çene Osteonekrozu GeliÅŸimi: Olgu Sunumu. Esmaeilzadeh, Sina; Şen, Ekin İlke; Aydın, Tuğba; Dernek, Bahar; Eskiyurt, Nurten // Turkish Journal of Osteoporosis / Turk Osteoporoz Dergisi;Aug2014, Vol. 20 Issue 2, p75 

    Clinical importance of the bisphosphonate-related osteonecrosis of the jaw (BRONJ) which is one of the serious side effects of bisphosphonates is increasing due to the widespread use of bisphosphonates in the treatment of osteoporosis. Since current treatment options for the BRONJ are limited,...

  • Osteonecrosis of the jaw is becoming more common. Loukota, Richard A. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/15/2012, Vol. 345 Issue 7874, p29 

    A letter to the editor is presented in response to the article "Bisphosphonates in the treatment of osteoporosis," by K.E. Poole and J.E. Compston in the May 2003 issue.

  • Bisphosphonate-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. Heng, Christine; Badner, Victor M.; Akkas, Tasios G.; Johnson, Rosemary; Yeo, Yvon // American Family Physician;6/15/2012, Vol. 85 Issue 12, p1135 

    The authors discuss the risk of bisphosphonate-related osteonecrosis of the jaw in individuals who are taking bisphosphonates for osteoporosis, particularly in the U.S. They cite the definition by the American and Canadian Associations of Oral and Maxillofacial Surgeons of the condition....

  • Pamidronic acid/zoledronic acid.  // Reactions Weekly;4/19/2008, Issue 1198, p35 

    The article describes the cases of two patients who developed osteonecrosis of the jaw while receiving treatment with biphosphonates. The first case was a 64-year-old man with prostate cancer and pulmonary, bone and nodal metastases and was given zoledronic acid. Another case was a 58-year-old...

  • AAOMS issues position paper expands scope of Medication-Related Osteonecrosis of the Jaw (MRONJ)  // Dental Assistant;Jul/Aug2014, Vol. 83 Issue 4, p38 

    The article reports that the American Association of Oral and Maxillofacial Surgeons (AAOMS) has released a position paper which expands the scope of Medication Related Osteonecrosis of the Jaw (MRONJ). It says that the paper provides guidance on decision making related to MRONJ risk, diagnosis...

  • Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat. Frieder Bauss; Thomas Pfister; Socrates Papapoulos // Journal of Bone & Mineral Metabolism;Jul2008, Vol. 26 Issue 4, p406 

    Abstract  Intravenous bisphosphonates may be involved in the development of osteonecrosis of the jaw (ONJ). However, a mechanistic causality has not been demonstrated. To evaluate whether there is higher drug uptake by the jaw versus other bones that might be involved in ONJ pathogenesis,...

  • Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw. Janovska, Zuzana; Mottl, Radovan; Slezak, Radovan // Biomedical Papers of the Medical Faculty of Palacky University i;Jun2015, Vol. 159 Issue 2, p313 

    Aim. This article covers the authors' experience with the treatment of bisphosphonate-related osteonecrosis of the jaw in 11 individuals. Methods. A retrospective study of patients diagnosed and treated for bisphosphonate-related osteonecrosis of the jaw at the Department of Dentistry,...

  • Aquacell® Ag i ozonska terapija u liječenju bisfosfonatima inducirane osteonekroze čeljusti (BIONJ): prikaz slučaja. Brakus, Ivan; Brakus, Ratka Borić; Poljak, Kolja; Zore, Irina Filipović // Acta Stomatologica Croatica;2013, Vol. 47 Issue 3, p241 

    Objective: Bisphosphonate induced osteonecrosis of the jaw (BIONJ) is often seen in oncologic patients with bone metastasis, who are treated with intravenous bisphosphonates as a result of elective dental treatment. Clinical course: We present a case report of a 68-year-old patient with BIONJ in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics